
Exagen (NASDAQ:XGN) brought in sales totaling $10.39 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 45.64%, resulting in a loss of $10.27 million. In Q4, Exagen brought in $12.69 million in sales but lost $7.05 million in earnings.